Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Momordica Charantia on Glycemic Control and Insulin Resistance in Type 2 Diabetes

NCT00823953 is registered in ClinicalTrials.gov with Services Hospital, Lahore as lead sponsor.

NCT NCT00823953
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00823953 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Momordica Charantia on Glycemic Control and Insulin Resistance in Type 2 Diabetes
Lead sponsor
Services Hospital, Lahore
Phase
Phase 2
Overall status
Withdrawn
Start date
November 30, 2008
Completion date
February 28, 2009
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes